![1]() - News- SGLT-2 inhibitors promising for heart failure prevention, not treatment- January 12, 2019- LOS ANGELES – The combination of heart failure and diabetes is particularly lethal. 
![1]() - News- New diabetes drugs solidify their cardiovascular and renal benefits- January 7, 2019- CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since. 
![1]() - News- Nasal glucagon ‘viable alternative’ to intramuscular administration- November 20, 2018- BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon. 
![1]() - Opinion- Transforming glycemic control at Norwalk Hospital- November 20, 2018- Norwalk Hospital created a Glycemic Care Team to focus on improving the quality of care for inpatients with diabetes. 
![1]() - News- Perioperative diabetes and HbA1c in mortality- October 4, 2018- Do preoperative hemoglobin A1c (HbA1c) and perioperative glucose predict outcomes in patients undergoing noncardiac and cardiac surgeries? 
![1]() - News- Plan now for outpatient diabetes tech in the hospital- September 4, 2018- ORLANDO – Getting ahead of the diabetes tech curve. 
![1]() - News- Hospitalists target inpatient glycemic control- August 13, 2018- Hyperglycemia in hospitalized patients is an extraordinarily common and growing problem. 
![1]() - News- Intranasal naloxone promising for type 1 hypoglycemia- July 17, 2018- ORLANDO – This development could help prevent autonomic failure in T1DM patients. 
![1]() - News- Closed-loop insulin control for T2DM is feasible in hospital setting- July 12, 2018- ORLANDO – Noncritical patients tolerated automated devices and had fewer clinically significant hypoglycemic events. 
![1]() - News- High risk of low glucose? Hospital alerts promise a crucial heads-up- July 2, 2018- Incidents of severe hypoglycemia dropped by 41% after system was put into place to warn doctors. 









